Shantani Proteome Analytics Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
2ndary - Private
Shantani Proteome Analytics General Information
Description
Operator of a protein analytics company intended to treat complex medical diseases. The company uses modern protein chemistry and proteomics methods to identify and validate clinically relevant novel drug targets for prevailing diseases, enabling medical research institutions to discover new drugs for unmet medical needs.
Contact Information
Website
www.shantani.comCorporate Office
- Office 302 and 303, 3rd Floor, Vascon Eco Tower
- Baner Pashan Link Road
- Pune, Maharashtra 411045
- India
Corporate Office
- Office 302 and 303, 3rd Floor, Vascon Eco Tower
- Baner Pashan Link Road
- Pune, Maharashtra 411045
- India
Shantani Proteome Analytics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 01-Apr-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 25-Feb-2015 | Completed | Generating Revenue | |||
| 4. Grant | 01-Dec-2012 | Completed | Generating Revenue | |||
| 3. Seed Round | 17-Jul-2012 | Completed | Generating Revenue | |||
| 2. Grant | 01-Dec-2011 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | 01-May-2010 | Completed | Startup |
Shantani Proteome Analytics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preference | ||||||||
| Ordinary |
Shantani Proteome Analytics Patents
Shantani Proteome Analytics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-9737510-B2 | Indazole compounds and a process for the preparation thereof | Inactive | 31-Jul-2013 | ||
| ES-2656475-T3 | New compounds of indazol and a process for the preparation of these | Active | 31-Jul-2013 | ||
| AU-2014297912-A1 | Novel indazole compounds and a process for the preparation thereof | Inactive | 31-Jul-2013 | ||
| CA-2919953-A1 | Novel indazole compounds and a process for the preparation thereof | Inactive | 31-Jul-2013 | ||
| EP-3027605-A1 | Novel indazole compounds and a process for the preparation thereof | Active | 31-Jul-2013 | A61K31/4184 |
Shantani Proteome Analytics Signals
Shantani Proteome Analytics Investments (1)
Shantani Proteome Analytics’s most recent deal was a Early Stage VC with Troph Bio. The deal was made on 01-Jul-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Troph Bio | 01-Jul-2017 | Early Stage VC | Diagnostic Equipment |
Shantani Proteome Analytics FAQs
-
When was Shantani Proteome Analytics founded?
Shantani Proteome Analytics was founded in 2010.
-
Where is Shantani Proteome Analytics headquartered?
Shantani Proteome Analytics is headquartered in Pune, India.
-
What is the size of Shantani Proteome Analytics?
Shantani Proteome Analytics has 12 total employees.
-
What industry is Shantani Proteome Analytics in?
Shantani Proteome Analytics’s primary industry is Drug Discovery.
-
Is Shantani Proteome Analytics a private or public company?
Shantani Proteome Analytics is a Private company.
-
What is Shantani Proteome Analytics’s current revenue?
The current revenue for Shantani Proteome Analytics is .
-
How much funding has Shantani Proteome Analytics raised over time?
Shantani Proteome Analytics has raised $485K.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process